Etienne Baudoux
Etienne Baudoux
CHU Liège
Adresse e-mail validée de
Citée par
Citée par
Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched …
F Baron, C Lechanteur, E Willems, F Bruck, E Baudoux, L Seidel, ...
Biology of blood and marrow transplantation 16 (6), 838-847, 2010
Clinical-scale expansion of mesenchymal stromal cells: a large banking experience
C Lechanteur, A Briquet, O Giet, O Delloye, E Baudoux, Y Beguin
J Transl Med 14, 145, 2016
Infusion of mesenchymal stromal cells after deceased liver transplantation: A phase I–II, open-label, clinical study
O Detry, M Vandermeulen, MH Delbouille, J Somja, N Bletard, A Briquet, ...
Journal of hepatology 67 (1), 47-55, 2017
Family-directed umbilical cord blood banking
E Gluckman, A Ruggeri, V Rocha, E Baudoux, M Boo, J Kurtzberg, ...
Haematologica 96 (11), 1700, 2011
Effect of HLA-matching recipients to donor noninherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy
V Rocha, S Spellman, MJ Zhang, A Ruggeri, D Purtill, C Brady, ...
Biology of Blood and Marrow Transplantation 18 (12), 1890-1896, 2012
Infusion of third-party mesenchymal stromal cells after kidney transplantation: a phase I-II, open-label, clinical study
P Erpicum, L Weekers, O Detry, C Bonvoisin, MH Delbouille, C Grégoire, ...
Kidney international 95 (3), 693-707, 2019
Inefficacy of autologous bone marrow concentrate in stage three osteonecrosis: a randomized controlled double-blind trial
JP Hauzeur, V De Maertelaer, E Baudoux, M Malaise, Y Beguin, V Gangji
International Orthopaedics 42, 1429-1435, 2018
Mesenchymal Stromal Cell Therapy for Inflammatory Bowel Diseases
C Grégoire, C Lechanteur, A Briquet, É Baudoux, F Baron, E Louis, ...
Alimentary pharmacology & therapeutics 45 (2), 205-221, 2017
Pre-emptive immunotherapy with CD8-depleted donor lymphocytes after CD34-selected allogeneic peripheral blood stem cell transplantation.
F Baron, J Siquet, N Schaaf-Lafontaine, E Baudoux, JP Hermanne, ...
haematologica 87 (1), 2002
Infusion of clinical‐grade enriched regulatory T cells delays experimental xenogeneic graft‐versus‐host disease
M Hannon, C Lechanteur, S Lucas, J Somja, L Seidel, L Belle, F Bruck, ...
Transfusion 54 (2), 353-363, 2014
Delayed massive immune hemolysis mediated by minor ABO incompatibility after allogeneic peripheral blood progenitor cell transplantation
JP Salmon, S Michaux, JP Hermanne, E Baudoux, C Gerard, ...
Transfusion 39 (8), 824-827, 1999
Correlation between P450 CYP1A1 inducibility, MspI genotype and lung cancer incidence
M Jacquet, V Lambert, E Baudoux, M Muller, P Kremers, J Gielen
European Journal of Cancer 32 (10), 1701-1706, 1996
Phase III randomized study comparing 5 or 10 μg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by …
M André, E Baudoux, D Bron, JL Canon, V D'Hondt, MF Fassotte, ...
Transfusion 43 (1), 50-57, 2003
Engraftment kinetics and graft failure after single umbilical cord blood transplantation using a myeloablative conditioning regimen
A Ruggeri, M Labopin, MP Sormani, G Sanz, J Sanz, F Volt, G Michel, ...
haematologica 99 (9), 1509, 2014
Large-scale clinical expansion of mesenchymal stem cells in the GMP-compliant, closed automated quantum® cell expansion system: comparison with expansion in traditional T-flasks
Journal of Stem Cell Research and Therapy 4 (8), 2014
Cord blood banking
A Brand, P Rebulla, CP Engelfriet, HW Reesink, Y Beguin, E Baudoux, ...
Vox Sanguinis: 95 (4), 335, 2008
Hematopoietic recovery in cancer patients after transplantation of autologous peripheral blood CD34+ cells or unmanipulated peripheral blood stem and progenitor cells
Y Beguin, E Baudoux, B Sautois, V Fraipont, N Schaaf‐Lafontaine, ...
Transfusion 38 (2), 199-208, 1998
Optimization of recombinant human erythropoietin therapy after allogeneic hematopoietic stem cell transplantation
F Baron, B Sautois, E Baudoux, G Matus, G Fillet, Y Beguin
Experimental hematology 30 (6), 546-554, 2002
T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation
F Baron, N Schaaf-Lafontaine, S Humblet-Baron, N Meuris, E Castermans, ...
Transplantation 76 (12), 1705-1713, 2003
Nonmyeloablative stem cell transplantation with CD8-depleted or CD34-selected peripheral blood stem cells
F Baron, E Baudoux, P Frère, S Tourqui, N Schaaf-Lafontaine, R Greimers, ...
Journal of hematotherapy & stem cell research 11 (2), 301-314, 2002
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20